Global and United States Circulating Biomarker In-Depth Research Report 2017-2022
The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.
This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Circulating Biomarker industry.
Major Companies
Circulating Biomarker Market, by Cancer Type
This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Circulating Biomarker industry.
Major Companies
- Biocept Inc (U.S.)
- Myriad Genetics (U.S.)
- QIAGEN (Netherlands)
- Roche (Switzerland)
- Bio-Rad Laboratories (U.S.)
- Trovagene (U.S.)
- Guardant Health (U.S.)
- Janssen Diagnostics (U.S.)
- Fraunhofer-Gesellschaft (Germany)
- MDxHealth SA (U.S.)
- North America
- United States
- California
- Texas
- New York
- Others
- Canada
- Latin America
- Mexico
- Brazil
- Argentina
- Others
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Netherland
- Others
- Asia & Pacific
- China
- Japan
- India
- Korea
- Australia
- Southeast Asia
- Indonesia
- Thailand
- Philippines
- Vietnam
- Singapore
- Malaysia
- Others
- Africa & Middle East
- South Africa
- Egypt
- Turkey
- Saudi Arabia
- Iran
- Others
Circulating Biomarker Market, by Cancer Type
- Lung
- Breast
- Colorectal
- Prostate
- Circulating Tumor Cells
- Circulating Tumor DNA
- Reference Laboratory
- Research Centers
CHAPTER ONE GLOBAL CIRCULATING BIOMARKER MARKET OVERVIEW
1.1 Global Circulating Biomarker Market Sales Volume Revenue and Price 2012-2017
1.2 Circulating Biomarker, by Cancer Type 2012-2017
1.2.1 Global Circulating Biomarker Sales Market Share by Cancer Type 2012-2017
1.2.2 Global Circulating Biomarker Revenue Market Share by Cancer Type 2012-2017
1.2.3 Global Circulating Biomarker Price by Cancer Type 2012-2017
1.2.4 Lung
1.2.5 Breast
1.2.6 Colorectal
1.2.7 Prostate
1.3 Circulating Biomarker, by Product 2012-2017
1.3.1 Global Circulating Biomarker Sales Market Share by Product 2012-2017
1.3.2 Global Circulating Biomarker Revenue Market Share by Product 2012-2017
1.3.3 Global Circulating Biomarker Price by Product 2012-2017
1.3.4 Circulating Tumor Cells
1.3.5 Circulating Tumor DNA
CHAPTER TWO UNITED STATES CIRCULATING BIOMARKER MARKET OVERVIEW
2.1 United States Circulating Biomarker Market Sales Volume Revenue and Price 2012-2017
2.2 Circulating Biomarker, by Cancer Type 2012-2017
2.2.1 United States Circulating Biomarker Sales Market Share by Cancer Type 2012-2017
2.2.2 United States Circulating Biomarker Revenue Market Share by Cancer Type 2012-2017
2.2.3 United States Circulating Biomarker Price by Cancer Type 2012-2017
2.2.4 Lung
2.2.5 Breast
2.2.6 Colorectal
2.2.7 Prostate
2.3 Circulating Biomarker, by Product 2012-2017
2.3.1 United States Circulating Biomarker Sales Market Share by Product 2012-2017
2.3.2 United States Circulating Biomarker Revenue Market Share by Product 2012-2017
2.3.3 United States Circulating Biomarker Price by Product 2012-2017
2.3.4 Circulating Tumor Cells
2.3.5 Circulating Tumor DNA
CHAPTER THREE CIRCULATING BIOMARKER BY REGIONS 2012-2017
3.1 Global Circulating Biomarker Sales Market Share by Regions 2012-2017
3.2 Global Circulating Biomarker Revenue Market Share by Regions 2012-2017
3.3 Global Circulating Biomarker Price by Regions 2012-2017
3.4 North America
3.4.1 United States
3.4.1.1 California
3.4.1.2 Texas
3.4.1.3 New York
3.4.1.4 Others in United States
3.4.2 Canada
3.5 Latin America
3.5.1 Mexico
3.5.2 Brazil
3.5.3 Argentina
3.5.4 Others in Latin America
3.6 Europe
3.6.1 Germany
3.6.2 United Kingdom
3.6.3 France
3.6.4 Italy
3.6.5 Spain
3.6.6 Russia
3.6.7 Netherland
3.6.8 Others in Europe
3.7 Asia & Pacific
3.7.1 China
3.7.2 Japan
3.7.3 India
3.7.4 Korea
3.7.5 Australia
3.7.6 Southeast Asia
3.7.6.1 Indonesia
3.7.6.2 Thailand
3.7.6.3 Philippines
3.7.6.4 Vietnam
3.7.6.5 Singapore
3.7.6.6 Malaysia
3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
3.8.1 South Africa
3.8.2 Egypt
3.8.3 Turkey
3.8.4 Saudi Arabia
3.8.5 Iran
3.8.6 Others in Africa & Middle East
CHAPTER FOUR GLOBAL CIRCULATING BIOMARKER BY COMPANIES 2012-2017
4.1 Global Circulating Biomarker Sales Volume Market Share by Companies 2012-2017
4.2 Global Circulating Biomarker Revenue Share by Companies 2012-2017
4.3 Global Top Companies Circulating Biomarker Key Product Model and Market Performance
4.4 Global Top Companies Circulating Biomarker Key Target Consumers and Market Performance
CHAPTER FIVE UNITED STATES CIRCULATING BIOMARKER BY COMPANIES 2012-2017
5.1 United States Circulating Biomarker Sales Volume Market Share by Companies 2012-2017
5.2 United States Circulating Biomarker Revenue Share by Companies 2012-2017
5.3 United States Top Companies Circulating Biomarker Key Product Model and Market Performance
5.4 United States Top Companies Circulating Biomarker Key Target Consumers and Market Performance
CHAPTER SIX GLOBAL CIRCULATING BIOMARKER BY CONSUMER 2012-2017
6.1 Global Circulating Biomarker Sales Market Share by Consumer 2012-2017
6.2 Reference Laboratory
6.3 Research Centers
6.4 Consuming Habit and Preference
CHAPTER SEVEN GLOBAL CIRCULATING BIOMARKER BY CONSUMER 2012-2017
7.1 Global Circulating Biomarker Sales Market Share by Consumer 2012-2017
7.2 Reference Laboratory
7.3 Research Centers
7.4 Consuming Habit and Preference
CHAPTER EIGHT TOP COMPANIES PROFILE
8.1 Biocept Inc (U.S.)
8.1.1 Biocept Inc (U.S.) Company Details and Competitors
8.1.2 Biocept Inc (U.S.) Key Circulating Biomarker Models and Performance
8.1.3 Biocept Inc (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.1.4 Biocept Inc (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.2 Myriad Genetics (U.S.)
8.2.1 Myriad Genetics (U.S.) Company Details and Competitors
8.2.2 Myriad Genetics (U.S.) Key Circulating Biomarker Models and Performance
8.2.3 Myriad Genetics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.2.4 Myriad Genetics (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.3 QIAGEN (Netherlands)
8.3.1 QIAGEN (Netherlands) Company Details and Competitors
8.3.2 QIAGEN (Netherlands) Key Circulating Biomarker Models and Performance
8.3.3 QIAGEN (Netherlands) Circulating Biomarker Business SWOT Analysis and Forecast
8.3.4 QIAGEN (Netherlands) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.4 Roche (Switzerland)
8.4.1 Roche (Switzerland) Company Details and Competitors
8.4.2 Roche (Switzerland) Key Circulating Biomarker Models and Performance
8.4.3 Roche (Switzerland) Circulating Biomarker Business SWOT Analysis and Forecast
8.4.4 Roche (Switzerland) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.5 Bio-Rad Laboratories (U.S.)
8.5.1 Bio-Rad Laboratories (U.S.) Company Details and Competitors
8.5.2 Bio-Rad Laboratories (U.S.) Key Circulating Biomarker Models and Performance
8.5.3 Bio-Rad Laboratories (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.5.4 Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.6 Trovagene (U.S.)
8.6.1 Trovagene (U.S.) Company Details and Competitors
8.6.2 Trovagene (U.S.) Key Circulating Biomarker Models and Performance
8.6.3 Trovagene (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.6.4 Trovagene (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.7 Guardant Health (U.S.)
8.7.1 Guardant Health (U.S.) Company Details and Competitors
8.7.2 Guardant Health (U.S.) Key Circulating Biomarker Models and Performance
8.7.3 Guardant Health (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.7.4 Guardant Health (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.8 Janssen Diagnostics (U.S.)
8.8.1 Janssen Diagnostics (U.S.) Company Details and Competitors
8.8.2 Janssen Diagnostics (U.S.) Key Circulating Biomarker Models and Performance
8.8.3 Janssen Diagnostics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.8.4 Janssen Diagnostics (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.9 Fraunhofer-Gesellschaft (Germany)
8.9.1 Fraunhofer-Gesellschaft (Germany) Company Details and Competitors
8.9.2 Fraunhofer-Gesellschaft (Germany) Key Circulating Biomarker Models and Performance
8.9.3 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Business SWOT Analysis and Forecast
8.9.4 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.10 MDxHealth SA (U.S.)
8.10.1 MDxHealth SA (U.S.) Company Details and Competitors
8.10.2 MDxHealth SA (U.S.) Key Circulating Biomarker Models and Performance
8.10.3 MDxHealth SA (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.10.4 MDxHealth SA (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN
9.1 Circulating Biomarker Industry Chain Structure
9.1.1 R&D
9.1.2 Raw Materials (Components)
9.1.3 Manufacturing Plants
9.1.4 Regional Trading (Import Export and Local Sales)
9.1.5 Online Sales Channel
9.1.6 Offline Channel
9.1.7 End Users
9.2 Circulating Biomarker Manufacturing
9.2.1 Key Components
9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment
CHAPTER TEN GLOBAL CIRCULATING BIOMARKER MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Circulating Biomarker Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
10.3 Global Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
10.4 Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
10.5 Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
CHAPTER ELEVEN UNITED STATES CIRCULATING BIOMARKER MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 United States Circulating Biomarker Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
11.3 United States Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
11.4 United States Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
11.5 United States Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION
12.1 Development Trend
12.2 Research Conclusion
CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
1.1 Global Circulating Biomarker Market Sales Volume Revenue and Price 2012-2017
1.2 Circulating Biomarker, by Cancer Type 2012-2017
1.2.1 Global Circulating Biomarker Sales Market Share by Cancer Type 2012-2017
1.2.2 Global Circulating Biomarker Revenue Market Share by Cancer Type 2012-2017
1.2.3 Global Circulating Biomarker Price by Cancer Type 2012-2017
1.2.4 Lung
1.2.5 Breast
1.2.6 Colorectal
1.2.7 Prostate
1.3 Circulating Biomarker, by Product 2012-2017
1.3.1 Global Circulating Biomarker Sales Market Share by Product 2012-2017
1.3.2 Global Circulating Biomarker Revenue Market Share by Product 2012-2017
1.3.3 Global Circulating Biomarker Price by Product 2012-2017
1.3.4 Circulating Tumor Cells
1.3.5 Circulating Tumor DNA
CHAPTER TWO UNITED STATES CIRCULATING BIOMARKER MARKET OVERVIEW
2.1 United States Circulating Biomarker Market Sales Volume Revenue and Price 2012-2017
2.2 Circulating Biomarker, by Cancer Type 2012-2017
2.2.1 United States Circulating Biomarker Sales Market Share by Cancer Type 2012-2017
2.2.2 United States Circulating Biomarker Revenue Market Share by Cancer Type 2012-2017
2.2.3 United States Circulating Biomarker Price by Cancer Type 2012-2017
2.2.4 Lung
2.2.5 Breast
2.2.6 Colorectal
2.2.7 Prostate
2.3 Circulating Biomarker, by Product 2012-2017
2.3.1 United States Circulating Biomarker Sales Market Share by Product 2012-2017
2.3.2 United States Circulating Biomarker Revenue Market Share by Product 2012-2017
2.3.3 United States Circulating Biomarker Price by Product 2012-2017
2.3.4 Circulating Tumor Cells
2.3.5 Circulating Tumor DNA
CHAPTER THREE CIRCULATING BIOMARKER BY REGIONS 2012-2017
3.1 Global Circulating Biomarker Sales Market Share by Regions 2012-2017
3.2 Global Circulating Biomarker Revenue Market Share by Regions 2012-2017
3.3 Global Circulating Biomarker Price by Regions 2012-2017
3.4 North America
3.4.1 United States
3.4.1.1 California
3.4.1.2 Texas
3.4.1.3 New York
3.4.1.4 Others in United States
3.4.2 Canada
3.5 Latin America
3.5.1 Mexico
3.5.2 Brazil
3.5.3 Argentina
3.5.4 Others in Latin America
3.6 Europe
3.6.1 Germany
3.6.2 United Kingdom
3.6.3 France
3.6.4 Italy
3.6.5 Spain
3.6.6 Russia
3.6.7 Netherland
3.6.8 Others in Europe
3.7 Asia & Pacific
3.7.1 China
3.7.2 Japan
3.7.3 India
3.7.4 Korea
3.7.5 Australia
3.7.6 Southeast Asia
3.7.6.1 Indonesia
3.7.6.2 Thailand
3.7.6.3 Philippines
3.7.6.4 Vietnam
3.7.6.5 Singapore
3.7.6.6 Malaysia
3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
3.8.1 South Africa
3.8.2 Egypt
3.8.3 Turkey
3.8.4 Saudi Arabia
3.8.5 Iran
3.8.6 Others in Africa & Middle East
CHAPTER FOUR GLOBAL CIRCULATING BIOMARKER BY COMPANIES 2012-2017
4.1 Global Circulating Biomarker Sales Volume Market Share by Companies 2012-2017
4.2 Global Circulating Biomarker Revenue Share by Companies 2012-2017
4.3 Global Top Companies Circulating Biomarker Key Product Model and Market Performance
4.4 Global Top Companies Circulating Biomarker Key Target Consumers and Market Performance
CHAPTER FIVE UNITED STATES CIRCULATING BIOMARKER BY COMPANIES 2012-2017
5.1 United States Circulating Biomarker Sales Volume Market Share by Companies 2012-2017
5.2 United States Circulating Biomarker Revenue Share by Companies 2012-2017
5.3 United States Top Companies Circulating Biomarker Key Product Model and Market Performance
5.4 United States Top Companies Circulating Biomarker Key Target Consumers and Market Performance
CHAPTER SIX GLOBAL CIRCULATING BIOMARKER BY CONSUMER 2012-2017
6.1 Global Circulating Biomarker Sales Market Share by Consumer 2012-2017
6.2 Reference Laboratory
6.3 Research Centers
6.4 Consuming Habit and Preference
CHAPTER SEVEN GLOBAL CIRCULATING BIOMARKER BY CONSUMER 2012-2017
7.1 Global Circulating Biomarker Sales Market Share by Consumer 2012-2017
7.2 Reference Laboratory
7.3 Research Centers
7.4 Consuming Habit and Preference
CHAPTER EIGHT TOP COMPANIES PROFILE
8.1 Biocept Inc (U.S.)
8.1.1 Biocept Inc (U.S.) Company Details and Competitors
8.1.2 Biocept Inc (U.S.) Key Circulating Biomarker Models and Performance
8.1.3 Biocept Inc (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.1.4 Biocept Inc (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.2 Myriad Genetics (U.S.)
8.2.1 Myriad Genetics (U.S.) Company Details and Competitors
8.2.2 Myriad Genetics (U.S.) Key Circulating Biomarker Models and Performance
8.2.3 Myriad Genetics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.2.4 Myriad Genetics (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.3 QIAGEN (Netherlands)
8.3.1 QIAGEN (Netherlands) Company Details and Competitors
8.3.2 QIAGEN (Netherlands) Key Circulating Biomarker Models and Performance
8.3.3 QIAGEN (Netherlands) Circulating Biomarker Business SWOT Analysis and Forecast
8.3.4 QIAGEN (Netherlands) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.4 Roche (Switzerland)
8.4.1 Roche (Switzerland) Company Details and Competitors
8.4.2 Roche (Switzerland) Key Circulating Biomarker Models and Performance
8.4.3 Roche (Switzerland) Circulating Biomarker Business SWOT Analysis and Forecast
8.4.4 Roche (Switzerland) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.5 Bio-Rad Laboratories (U.S.)
8.5.1 Bio-Rad Laboratories (U.S.) Company Details and Competitors
8.5.2 Bio-Rad Laboratories (U.S.) Key Circulating Biomarker Models and Performance
8.5.3 Bio-Rad Laboratories (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.5.4 Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.6 Trovagene (U.S.)
8.6.1 Trovagene (U.S.) Company Details and Competitors
8.6.2 Trovagene (U.S.) Key Circulating Biomarker Models and Performance
8.6.3 Trovagene (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.6.4 Trovagene (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.7 Guardant Health (U.S.)
8.7.1 Guardant Health (U.S.) Company Details and Competitors
8.7.2 Guardant Health (U.S.) Key Circulating Biomarker Models and Performance
8.7.3 Guardant Health (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.7.4 Guardant Health (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.8 Janssen Diagnostics (U.S.)
8.8.1 Janssen Diagnostics (U.S.) Company Details and Competitors
8.8.2 Janssen Diagnostics (U.S.) Key Circulating Biomarker Models and Performance
8.8.3 Janssen Diagnostics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.8.4 Janssen Diagnostics (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.9 Fraunhofer-Gesellschaft (Germany)
8.9.1 Fraunhofer-Gesellschaft (Germany) Company Details and Competitors
8.9.2 Fraunhofer-Gesellschaft (Germany) Key Circulating Biomarker Models and Performance
8.9.3 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Business SWOT Analysis and Forecast
8.9.4 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
8.10 MDxHealth SA (U.S.)
8.10.1 MDxHealth SA (U.S.) Company Details and Competitors
8.10.2 MDxHealth SA (U.S.) Key Circulating Biomarker Models and Performance
8.10.3 MDxHealth SA (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
8.10.4 MDxHealth SA (U.S.) Circulating Biomarker Sales Volume Revenue Price Cost and Gross Margin
CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN
9.1 Circulating Biomarker Industry Chain Structure
9.1.1 R&D
9.1.2 Raw Materials (Components)
9.1.3 Manufacturing Plants
9.1.4 Regional Trading (Import Export and Local Sales)
9.1.5 Online Sales Channel
9.1.6 Offline Channel
9.1.7 End Users
9.2 Circulating Biomarker Manufacturing
9.2.1 Key Components
9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment
CHAPTER TEN GLOBAL CIRCULATING BIOMARKER MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
10.1 Global Circulating Biomarker Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
10.3 Global Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
10.4 Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
10.5 Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
CHAPTER ELEVEN UNITED STATES CIRCULATING BIOMARKER MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 United States Circulating Biomarker Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
11.3 United States Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
11.4 United States Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
11.5 United States Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION
12.1 Development Trend
12.2 Research Conclusion
CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES AND FIGURES
Table Global Circulating Biomarker Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Global Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Circulating Biomarker Sales Volume (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Cancer Type (2012-2017)
Table Global Circulating Biomarker Sales Market Share by Cancer Type (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Cancer Type in 2016
Table Global Circulating Biomarker Revenue (Million USD) by Cancer Type (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Cancer Type (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Cancer Type in 2016
Table Global Circulating Biomarker Price (USD/Unit) by Cancer Type (2012-2017)
Table Top Companies of Lung Circulating Biomarker Products List
Figure Global Lung Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Breast Circulating Biomarker Products List
Figure Global Breast Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Colorectal Circulating Biomarker Products List
Figure Global Colorectal Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Prostate Circulating Biomarker Products List
Figure Global Prostate Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Product (2012-2017)
Table Global Circulating Biomarker Sales Market Share by Product (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Product in 2016
Table Global Circulating Biomarker Revenue (Million USD) by Product (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Product (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Product in 2016
Table Global Circulating Biomarker Price (USD/Unit) by Product (2012-2017)
Table Top Companies of Circulating Tumor Cells Circulating Biomarker Products List
Figure Global Circulating Tumor Cells Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Circulating Tumor DNA Circulating Biomarker Products List
Figure Global Circulating Tumor DNA Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Figure United States Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Circulating Biomarker Sales Volume (K Units) and Growth Rate (2012-2017)
Table United States Circulating Biomarker Sales (K Units) by Cancer Type (2012-2017)
Table United States Circulating Biomarker Sales Market Share by Cancer Type (2012-2017)
Figure United States Circulating Biomarker Sales Market Share by Cancer Type in 2016
Table United States Circulating Biomarker Revenue (Million USD) by Cancer Type (2012-2017)
Table United States Circulating Biomarker Revenue Market Share by Cancer Type (2012-2017)
Figure United States Circulating Biomarker Revenue Market Share by Cancer Type in 2016
Table United States Circulating Biomarker Price (USD/Unit) by Cancer Type (2012-2017)
Table Top Companies of Lung Circulating Biomarker Products List
Figure United States Lung Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Breast Circulating Biomarker Products List
Figure United States Breast Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Colorectal Circulating Biomarker Products List
Figure United States Colorectal Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Prostate Circulating Biomarker Products List
Figure United States Prostate Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table United States Circulating Biomarker Sales (K Units) by Product (2012-2017)
Table United States Circulating Biomarker Sales Market Share by Product (2012-2017)
Figure United States Circulating Biomarker Sales Market Share by Product in 2016
Table United States Circulating Biomarker Revenue (Million USD) by Product (2012-2017)
Table United States Circulating Biomarker Revenue Market Share by Product (2012-2017)
Figure United States Circulating Biomarker Revenue Market Share by Product in 2016
Table United States Circulating Biomarker Price (USD/Unit) by Product (2012-2017)
Table Top Companies of Circulating Tumor Cells Circulating Biomarker Products List
Figure United States Circulating Tumor Cells Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Circulating Tumor DNA Circulating Biomarker Products List
Figure United States Circulating Tumor DNA Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Global Circulating Biomarker Sales Share by Regions (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Regions in 2016
Figure Global Circulating Biomarker Sales Market Share by Regions in 2017
Table Global Circulating Biomarker Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Regions (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Regions in 2016
Figure Global Circulating Biomarker Revenue Market Share by Regions in 2017
Table Global Circulating Biomarker Price (USD/Unit) by Regions (2012-2017)
Table North America Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table North America Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure North America Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table United States Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table United States Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure United States Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Latin America Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Latin America Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Europe Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Europe Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure Europe Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Asia & Pacific Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Asia & Pacific Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Africa & Middle East Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Africa & Middle East Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales Volume (K Units) by Major Companies (2012-2017)
Table Global Circulating Biomarker Sales Volume Market Share by Major Companies (2012-2017)
Figure Global Circulating Biomarker Sales Volume Market Share by Major Companies 2016
Figure Global Circulating Biomarker Sales Volume Market Share by Major Companies 2017
Table Global Circulating Biomarker Revenue (Million USD) by Major Companies (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Major Companies (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Major Companies 2016
Figure Global Circulating Biomarker Revenue Market Share by Major Companies 2017
Table Global Top Companies Key Product Model and Market Performance
Table Global Top Companies Key Target Consumers and Market Performance
Table United States Circulating Biomarker Sales Volume (K Units) by Top Companies (2012-2017)
Table United States Circulating Biomarker Sales Volume Market Share by Top Companies (2012-2017)
Figure United States Circulating Biomarker Sales Volume Market Share by Top Companies 2016
Figure United States Circulating Biomarker Sales Volume Market Share by Top Companies 2017
Table United States Circulating Biomarker Revenue (Million USD) by Top Companies (2012-2017)
Table United States Circulating Biomarker Revenue Market Share by Top Companies (2012-2017)
Figure United States Circulating Biomarker Revenue Market Share by Top Companies 2016
Figure United States Circulating Biomarker Revenue Market Share by Top Companies 2017
Table United States Top Companies Key Product Model and Market Performance
Table United States Top Companies Key Target Consumers and Market Performance
Table Global Circulating Biomarker Sales (K Units) by Consumer (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Consumer (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Consumer in 2016
Figure Global Reference Laboratory Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Figure Global Research Centers Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table United States Circulating Biomarker Sales (K Units) by Consumer (2012-2017)
Figure United States Circulating Biomarker Sales Market Share by Consumer (2012-2017)
Figure United States Circulating Biomarker Sales Market Share by Consumer in 2016
Figure United States Reference Laboratory Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Figure United States Research Centers Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Biocept Inc (U.S.) Company Details and Competitors
Table Biocept Inc (U.S.) Key Circulating Biomarker Models and Performance
Table Biocept Inc (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Biocept Inc (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Myriad Genetics (U.S.) Company Details and Competitors
Table Myriad Genetics (U.S.) Key Circulating Biomarker Models and Performance
Table Myriad Genetics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Myriad Genetics (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table QIAGEN (Netherlands) Company Details and Competitors
Table QIAGEN (Netherlands) Key Circulating Biomarker Models and Performance
Table QIAGEN (Netherlands) Circulating Biomarker Business SWOT Analysis and Forecast
Table QIAGEN (Netherlands) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Roche (Switzerland) Company Details and Competitors
Table Roche (Switzerland) Key Circulating Biomarker Models and Performance
Table Roche (Switzerland) Circulating Biomarker Business SWOT Analysis and Forecast
Table Roche (Switzerland) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Bio-Rad Laboratories (U.S.) Company Details and Competitors
Table Bio-Rad Laboratories (U.S.) Key Circulating Biomarker Models and Performance
Table Bio-Rad Laboratories (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Bio-Rad Laboratories (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Trovagene (U.S.) Company Details and Competitors
Table Trovagene (U.S.) Key Circulating Biomarker Models and Performance
Table Trovagene (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Trovagene (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Guardant Health (U.S.) Company Details and Competitors
Table Guardant Health (U.S.) Key Circulating Biomarker Models and Performance
Table Guardant Health (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Guardant Health (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Janssen Diagnostics (U.S.) Company Details and Competitors
Table Janssen Diagnostics (U.S.) Key Circulating Biomarker Models and Performance
Table Janssen Diagnostics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Janssen Diagnostics (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Fraunhofer-Gesellschaft (Germany) Company Details and Competitors
Table Fraunhofer-Gesellschaft (Germany) Key Circulating Biomarker Models and Performance
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Business SWOT Analysis and Forecast
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table MDxHealth SA (U.S.) Company Details and Competitors
Table MDxHealth SA (U.S.) Key Circulating Biomarker Models and Performance
Table MDxHealth SA (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table MDxHealth SA (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Figure Global Circulating Biomarker Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Circulating Biomarker Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Circulating Biomarker Price (USD/Unit) Trend Forecast (2017-2022)
Table Global Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
Table Global Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Circulating Biomarker Sales Volume Share Forecast by Regions in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Application in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Cancer Type in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Product in 2022
Figure United States Circulating Biomarker Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure United States Circulating Biomarker Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Circulating Biomarker Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
Table United States Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Circulating Biomarker Sales Volume Share Forecast by Regions in 2022
Table United States Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
Figure United States Circulating Biomarker Sales Volume Market Share Forecast by Application (2017-2022)
Figure United States Circulating Biomarker Sales Volume Market Share Forecast by Application in 2022
Table United States Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure United States Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure United States Circulating Biomarker Sales Volume Market Share Forecast by Cancer Type in 2022
Table United States Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure United States Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure United States Circulating Biomarker Sales Volume Market Share Forecast by Product in 2022
Table Global Circulating Biomarker Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Figure Global Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Circulating Biomarker Sales Volume (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Cancer Type (2012-2017)
Table Global Circulating Biomarker Sales Market Share by Cancer Type (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Cancer Type in 2016
Table Global Circulating Biomarker Revenue (Million USD) by Cancer Type (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Cancer Type (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Cancer Type in 2016
Table Global Circulating Biomarker Price (USD/Unit) by Cancer Type (2012-2017)
Table Top Companies of Lung Circulating Biomarker Products List
Figure Global Lung Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Breast Circulating Biomarker Products List
Figure Global Breast Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Colorectal Circulating Biomarker Products List
Figure Global Colorectal Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Prostate Circulating Biomarker Products List
Figure Global Prostate Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Product (2012-2017)
Table Global Circulating Biomarker Sales Market Share by Product (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Product in 2016
Table Global Circulating Biomarker Revenue (Million USD) by Product (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Product (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Product in 2016
Table Global Circulating Biomarker Price (USD/Unit) by Product (2012-2017)
Table Top Companies of Circulating Tumor Cells Circulating Biomarker Products List
Figure Global Circulating Tumor Cells Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Circulating Tumor DNA Circulating Biomarker Products List
Figure Global Circulating Tumor DNA Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Figure United States Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Circulating Biomarker Sales Volume (K Units) and Growth Rate (2012-2017)
Table United States Circulating Biomarker Sales (K Units) by Cancer Type (2012-2017)
Table United States Circulating Biomarker Sales Market Share by Cancer Type (2012-2017)
Figure United States Circulating Biomarker Sales Market Share by Cancer Type in 2016
Table United States Circulating Biomarker Revenue (Million USD) by Cancer Type (2012-2017)
Table United States Circulating Biomarker Revenue Market Share by Cancer Type (2012-2017)
Figure United States Circulating Biomarker Revenue Market Share by Cancer Type in 2016
Table United States Circulating Biomarker Price (USD/Unit) by Cancer Type (2012-2017)
Table Top Companies of Lung Circulating Biomarker Products List
Figure United States Lung Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Breast Circulating Biomarker Products List
Figure United States Breast Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Colorectal Circulating Biomarker Products List
Figure United States Colorectal Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Prostate Circulating Biomarker Products List
Figure United States Prostate Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table United States Circulating Biomarker Sales (K Units) by Product (2012-2017)
Table United States Circulating Biomarker Sales Market Share by Product (2012-2017)
Figure United States Circulating Biomarker Sales Market Share by Product in 2016
Table United States Circulating Biomarker Revenue (Million USD) by Product (2012-2017)
Table United States Circulating Biomarker Revenue Market Share by Product (2012-2017)
Figure United States Circulating Biomarker Revenue Market Share by Product in 2016
Table United States Circulating Biomarker Price (USD/Unit) by Product (2012-2017)
Table Top Companies of Circulating Tumor Cells Circulating Biomarker Products List
Figure United States Circulating Tumor Cells Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Top Companies of Circulating Tumor DNA Circulating Biomarker Products List
Figure United States Circulating Tumor DNA Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Global Circulating Biomarker Sales Share by Regions (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Regions in 2016
Figure Global Circulating Biomarker Sales Market Share by Regions in 2017
Table Global Circulating Biomarker Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Regions (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Regions in 2016
Figure Global Circulating Biomarker Revenue Market Share by Regions in 2017
Table Global Circulating Biomarker Price (USD/Unit) by Regions (2012-2017)
Table North America Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table North America Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure North America Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table United States Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table United States Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure United States Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Latin America Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Latin America Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Europe Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Europe Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure Europe Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Asia & Pacific Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Asia & Pacific Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Africa & Middle East Circulating Biomarker Sales (K Units) by Regions (2012-2017)
Table Africa & Middle East Circulating Biomarker Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Global Circulating Biomarker Sales Volume (K Units) by Major Companies (2012-2017)
Table Global Circulating Biomarker Sales Volume Market Share by Major Companies (2012-2017)
Figure Global Circulating Biomarker Sales Volume Market Share by Major Companies 2016
Figure Global Circulating Biomarker Sales Volume Market Share by Major Companies 2017
Table Global Circulating Biomarker Revenue (Million USD) by Major Companies (2012-2017)
Table Global Circulating Biomarker Revenue Market Share by Major Companies (2012-2017)
Figure Global Circulating Biomarker Revenue Market Share by Major Companies 2016
Figure Global Circulating Biomarker Revenue Market Share by Major Companies 2017
Table Global Top Companies Key Product Model and Market Performance
Table Global Top Companies Key Target Consumers and Market Performance
Table United States Circulating Biomarker Sales Volume (K Units) by Top Companies (2012-2017)
Table United States Circulating Biomarker Sales Volume Market Share by Top Companies (2012-2017)
Figure United States Circulating Biomarker Sales Volume Market Share by Top Companies 2016
Figure United States Circulating Biomarker Sales Volume Market Share by Top Companies 2017
Table United States Circulating Biomarker Revenue (Million USD) by Top Companies (2012-2017)
Table United States Circulating Biomarker Revenue Market Share by Top Companies (2012-2017)
Figure United States Circulating Biomarker Revenue Market Share by Top Companies 2016
Figure United States Circulating Biomarker Revenue Market Share by Top Companies 2017
Table United States Top Companies Key Product Model and Market Performance
Table United States Top Companies Key Target Consumers and Market Performance
Table Global Circulating Biomarker Sales (K Units) by Consumer (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Consumer (2012-2017)
Figure Global Circulating Biomarker Sales Market Share by Consumer in 2016
Figure Global Reference Laboratory Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Figure Global Research Centers Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table United States Circulating Biomarker Sales (K Units) by Consumer (2012-2017)
Figure United States Circulating Biomarker Sales Market Share by Consumer (2012-2017)
Figure United States Circulating Biomarker Sales Market Share by Consumer in 2016
Figure United States Reference Laboratory Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Figure United States Research Centers Circulating Biomarker Sales (K Units) and Growth Rate (2012-2017)
Table Biocept Inc (U.S.) Company Details and Competitors
Table Biocept Inc (U.S.) Key Circulating Biomarker Models and Performance
Table Biocept Inc (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Biocept Inc (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Myriad Genetics (U.S.) Company Details and Competitors
Table Myriad Genetics (U.S.) Key Circulating Biomarker Models and Performance
Table Myriad Genetics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Myriad Genetics (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table QIAGEN (Netherlands) Company Details and Competitors
Table QIAGEN (Netherlands) Key Circulating Biomarker Models and Performance
Table QIAGEN (Netherlands) Circulating Biomarker Business SWOT Analysis and Forecast
Table QIAGEN (Netherlands) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Roche (Switzerland) Company Details and Competitors
Table Roche (Switzerland) Key Circulating Biomarker Models and Performance
Table Roche (Switzerland) Circulating Biomarker Business SWOT Analysis and Forecast
Table Roche (Switzerland) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Bio-Rad Laboratories (U.S.) Company Details and Competitors
Table Bio-Rad Laboratories (U.S.) Key Circulating Biomarker Models and Performance
Table Bio-Rad Laboratories (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Bio-Rad Laboratories (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Trovagene (U.S.) Company Details and Competitors
Table Trovagene (U.S.) Key Circulating Biomarker Models and Performance
Table Trovagene (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Trovagene (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Guardant Health (U.S.) Company Details and Competitors
Table Guardant Health (U.S.) Key Circulating Biomarker Models and Performance
Table Guardant Health (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Guardant Health (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Janssen Diagnostics (U.S.) Company Details and Competitors
Table Janssen Diagnostics (U.S.) Key Circulating Biomarker Models and Performance
Table Janssen Diagnostics (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table Janssen Diagnostics (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table Fraunhofer-Gesellschaft (Germany) Company Details and Competitors
Table Fraunhofer-Gesellschaft (Germany) Key Circulating Biomarker Models and Performance
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Business SWOT Analysis and Forecast
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Table MDxHealth SA (U.S.) Company Details and Competitors
Table MDxHealth SA (U.S.) Key Circulating Biomarker Models and Performance
Table MDxHealth SA (U.S.) Circulating Biomarker Business SWOT Analysis and Forecast
Table MDxHealth SA (U.S.) Circulating Biomarker Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales Market Share (%) in Global (2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Revenue Market Share (%) in Global (2012-2017)
Figure Global Circulating Biomarker Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Circulating Biomarker Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Circulating Biomarker Price (USD/Unit) Trend Forecast (2017-2022)
Table Global Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
Table Global Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Circulating Biomarker Sales Volume Share Forecast by Regions in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Application in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure Global Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Cancer Type in 2022
Table Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure Global Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Product in 2022
Figure United States Circulating Biomarker Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure United States Circulating Biomarker Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Circulating Biomarker Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
Table United States Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Circulating Biomarker Sales Volume Share Forecast by Regions in 2022
Table United States Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
Figure United States Circulating Biomarker Sales Volume Market Share Forecast by Application (2017-2022)
Figure United States Circulating Biomarker Sales Volume Market Share Forecast by Application in 2022
Table United States Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure United States Circulating Biomarker Sales (K Units) Forecast by Cancer Type (2017-2022)
Figure United States Circulating Biomarker Sales Volume Market Share Forecast by Cancer Type in 2022
Table United States Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure United States Circulating Biomarker Sales (K Units) Forecast by Product (2017-2022)
Figure United States Circulating Biomarker Sales Volume Market Share Forecast by Product in 2022
